AAAAAA

   
Results: 1-13 |
Results: 13
FEASIBILITY AND PHARMACOKINETIC STUDY OF A CHIMERIC ANTI-CD20 MONOCLONAL-ANTIBODY (IDEC-C2B8, RITUXIMAB) IN RELAPSED B-CELL LYMPHOMA
Authors: TOBINAI K KOBAYASHI Y NARABAYASHI M OGURA M KAGAMI Y MORISHIMA Y OHTSU T IGARASHI T SASAKI Y KINOSHITA T MURATE T
Citation: K. Tobinai et al., FEASIBILITY AND PHARMACOKINETIC STUDY OF A CHIMERIC ANTI-CD20 MONOCLONAL-ANTIBODY (IDEC-C2B8, RITUXIMAB) IN RELAPSED B-CELL LYMPHOMA, Annals of oncology, 9(5), 1998, pp. 527-534
CONSTRUCTION AND VALIDATION OF A PRACTICAL PROGNOSTIC INDEX FOR PATIENTS WITH METASTATIC BREAST-CANCER
Authors: YAMAMOTO N WATANABE T KATSUMATA N OMURO Y ANDO M FUKUDA H TOKUE Y NARABAYASHI M ADACHI I TAKASHIMA S
Citation: N. Yamamoto et al., CONSTRUCTION AND VALIDATION OF A PRACTICAL PROGNOSTIC INDEX FOR PATIENTS WITH METASTATIC BREAST-CANCER, Journal of clinical oncology, 16(7), 1998, pp. 2401-2408
CLINICAL CHARACTERISTICS OF PATIENTS WITH METASTATIC BREAST-CANCER WITH COMPLETE REMISSION FOLLOWING SYSTEMIC TREATMENT
Authors: YAMAMOTO N KATSUMATA N WATANABE T OMURO Y ANDO M NARABAYASHI M ADACHI I
Citation: N. Yamamoto et al., CLINICAL CHARACTERISTICS OF PATIENTS WITH METASTATIC BREAST-CANCER WITH COMPLETE REMISSION FOLLOWING SYSTEMIC TREATMENT, Japanese Journal of Clinical Oncology, 28(6), 1998, pp. 368-373
THROMBOTIC MICROANGIOPATHY OF HYPERACUTE ONSET AFTER AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN MALIGNANT-LYMPHOMA
Authors: TOGITANI K TAKEYAMA K YOKOZAWA T ANDOH M NARABAYASHI M KOBAYASHI Y TAKENAKA T TOBINAI K
Citation: K. Togitani et al., THROMBOTIC MICROANGIOPATHY OF HYPERACUTE ONSET AFTER AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN MALIGNANT-LYMPHOMA, Bone marrow transplantation, 21(12), 1998, pp. 1263-1266
PHASE-I STUDY OF CLADRIBINE (2-CHLORODEOXYADENOSINE) IN LYMPHOID MALIGNANCIES
Authors: TOBINAI K OGURA M HOTTA T KOBAYASHI Y NARABAYASHI M SUZUKI R KINOSHITA T KOZURU M UIKE N OHASHI Y
Citation: K. Tobinai et al., PHASE-I STUDY OF CLADRIBINE (2-CHLORODEOXYADENOSINE) IN LYMPHOID MALIGNANCIES, Japanese Journal of Clinical Oncology, 27(3), 1997, pp. 146-153
TRISOMY-3 IN GASTRIC LOW-GRADE MALT-ANALYSIS BY IN-SITU HYBRIDIZATIONON TOUCH SMEAR SAMPLES
Authors: KOBAYASHI Y ONO H SAITO D NARABAYASHI M TAKENAKA T TOBINAI K
Citation: Y. Kobayashi et al., TRISOMY-3 IN GASTRIC LOW-GRADE MALT-ANALYSIS BY IN-SITU HYBRIDIZATIONON TOUCH SMEAR SAMPLES, Blood, 90(10), 1997, pp. 3574-3574
PROGNOSTIC FACTORS AND A PREDICTIVE MODEL OF FOLLICULAR LYMPHOMA - A 25-YEAR STUDY AT A SINGLE INSTITUTION IN JAPAN
Authors: KATSUMATA N MATSUNO Y NAKAYAMA H TAKENAKA T KOBAYASHI Y TAKEYAMA K NARABAYASHI M FUKUSHIMA T YOKOZAWA T NAKATA M TAJIMA K IKEDA H TOBINAI K
Citation: N. Katsumata et al., PROGNOSTIC FACTORS AND A PREDICTIVE MODEL OF FOLLICULAR LYMPHOMA - A 25-YEAR STUDY AT A SINGLE INSTITUTION IN JAPAN, Japanese Journal of Clinical Oncology, 26(6), 1996, pp. 445-454
A LATE-PHASE-II STUDY OF RP56976 (DOCETAXEL) IN PATIENTS WITH ADVANCED OR RECURRENT BREAST-CANCER
Authors: ADACHI I WATANABE T TAKASHIMA S NARABAYASHI M HORIKOSHI N AOYAMA H TAGUCHI T
Citation: I. Adachi et al., A LATE-PHASE-II STUDY OF RP56976 (DOCETAXEL) IN PATIENTS WITH ADVANCED OR RECURRENT BREAST-CANCER, British Journal of Cancer, 73(2), 1996, pp. 210-216
EYELID METASTASIS FROM BREAST-CANCER SHOWING MARKED RESPONSE TO CHEMOTHERAPY
Authors: ZHANG GJ ADACHI I YIN DF NARABAYASHI M TOKUE Y WATANABE T KANEKO A TSUDA H ABE K
Citation: Gj. Zhang et al., EYELID METASTASIS FROM BREAST-CANCER SHOWING MARKED RESPONSE TO CHEMOTHERAPY, Japanese Journal of Clinical Oncology, 25(1), 1995, pp. 10-15
LOW-DOSE GRANULOCYTE-COLONY-STIMULATING FACTOR ENABLES THE EFFICIENT COLLECTION OF PERIPHERAL-BLOOD STEM-CELLS AFTER DISEASE-ORIENTED, CONVENTIONAL-DOSE CHEMOTHERAPY FOR BREAST-CANCER, MALIGNANT-LYMPHOMA AND GERM-CELL TUMOR
Authors: KOHNO A TAKEYAMA K NARABAYASHI M OKAMOTO R ADACHI I TOBINAI K SHIMOYAMA M
Citation: A. Kohno et al., LOW-DOSE GRANULOCYTE-COLONY-STIMULATING FACTOR ENABLES THE EFFICIENT COLLECTION OF PERIPHERAL-BLOOD STEM-CELLS AFTER DISEASE-ORIENTED, CONVENTIONAL-DOSE CHEMOTHERAPY FOR BREAST-CANCER, MALIGNANT-LYMPHOMA AND GERM-CELL TUMOR, Bone marrow transplantation, 15(1), 1995, pp. 49-54
DIFFERENCES IN CLINICOPATHOLOGICAL CHARACTERISTICS AND MAJOR PROGNOSTIC FACTORS BETWEEN B-LYMPHOMA AND PERIPHERAL T-LYMPHOMA EXCLUDING ADULT T-CELL LEUKEMIA-LYMPHOMA
Authors: SHIMOYAMA M OYAMA A TAJIMA K TOBINAI K MINATO K TAKENAKA T KONDA C TAKEYAMA K KOHNO A NARABAYASHI M TAMAYOSE K SUZUKI H KURITA S OHTA K MUKAI K WATANABE S SUCHI T
Citation: M. Shimoyama et al., DIFFERENCES IN CLINICOPATHOLOGICAL CHARACTERISTICS AND MAJOR PROGNOSTIC FACTORS BETWEEN B-LYMPHOMA AND PERIPHERAL T-LYMPHOMA EXCLUDING ADULT T-CELL LEUKEMIA-LYMPHOMA, Leukemia & lymphoma, 10(4-5), 1993, pp. 335-342
MX2 - MINO-3'-MORPHOLINO-13-DEOXY-10-HYDROXYCARMINOMYCIN (KRN8602) INREFRACTORY METASTATIC BREAST-CANCER - RESULTS OF A PRELIMINARY PHASE-II TRIAL
Authors: WATANABE T NARABAYASHI M HAGA S YAMADA Y KAWAMURA E ENOMOTO K KUSAMA M KIMURA K ADACHI I ABE O
Citation: T. Watanabe et al., MX2 - MINO-3'-MORPHOLINO-13-DEOXY-10-HYDROXYCARMINOMYCIN (KRN8602) INREFRACTORY METASTATIC BREAST-CANCER - RESULTS OF A PRELIMINARY PHASE-II TRIAL, Japanese Journal of Clinical Oncology, 23(4), 1993, pp. 246-249
TOXICITY GRADING CRITERIA OF THE JAPAN CLINICAL ONCOLOGY GROUP
Authors: TOBINAI K KOHNO A SHIMADA Y WATANABE T TAMURA T TAKEYAMA K NARABAYASHI M FUKUTOMI T KONDO H SHIMOYAMA M SUEMASU K
Citation: K. Tobinai et al., TOXICITY GRADING CRITERIA OF THE JAPAN CLINICAL ONCOLOGY GROUP, Japanese Journal of Clinical Oncology, 23(4), 1993, pp. 250-257
Risultati: 1-13 |